Breast Guardian

What is Breast Cancer

1 in 15 women are prone to Breast Cancer  during a lifetime.


Breast cancer is getting more common especially in the 45-80 year age group. Compared with the median age of 62 in the United States and that of 60 in Australia, the median age of diagnosis in Hong Kong is 56, which shows that the patients are relatively young. According to the recent data*, the mortality rate of breasts cancer is 12.5% of all cancers in 2018, which is not neglectable.

*Source: Hong Kong Cancer Registry, Hospital Authority & Hong Kong Well Women Centre

Discovery at late-stage causes cancer a fatal disease. According to China Cancer Registry Annual Report, only 5.2% of patients were diagnosed with breast cancer through regular physical examination and early screening, while 82.1% of patients were diagnosed when they took the initiative to seek medical attention as they were with obvious symptoms. In this case, most of them were in the middle or late stage.

With the advancement of treatment methods, the five-year survival rate for early-stage cancer can be as high as 80-90%, however the early detection rate is only 20-30% on average. The main reasons are (1) early stage (below 5mm) symptoms are not obvious (2) ultrasound and X-ray examination are not sensitive (3) malignant tumors above 5mm grow and metastasize rapidly.

Stage 0

There is no evidence of cancer cells or non-cancerous abnormal cells breaking out of the part of the breast in which they started, or getting through to or invading neighboring normal tissue.

Five-year survival rate

Over 99.3%

Stage I

The tumor measures up to 2 cm and the cancer has not spread outside the breast; no lymph nodes are involved.

Five-year survival rate


Stage II

The tumor is larger than 2 cm but no larger than 5 cm; cancer has spread to 1 to 3 axillary lymph nodes or to lymph nodes near the breastbone

Five-year survival rate

Over 99.3%

Stage III

the tumor is larger than 5 cm; small groups of breast cancer cells (0.2–2 mm) are found in the lymph nodes

Five-year survival rate


Stage IV

Invasive breast cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body, such as the lungs, distant lymph nodes, skin, bones, liver, or brain.

Five-year survival rate


Breast Biorhythm Monitoring System

The system is based on the theories of thermal changes in cell metabolism. It collects cellular biorhythm data via smart sensors and transmits to cloud database in real time for comparison and analysis.

After analysis, there will be assessment reports sent to the user’s mobile phone and provide health risk warnings and suggestions.

Users can make decisions on their next-steps accordingly such as taking a medical examination, realizing breast health risk management at home.

"It is a good initiative. The staff is very helpful. I felt there is room for more development in product design, apps, etc..."

User a

"User friendly, new technology"

User b

Privacy Policy           Notes to User                                                                                                                                                                                          Copyright © 2023 HK Bio-rhythm R&D Company Ltd. All right reserved.